AARP Eye Center
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement in response to the Centers for Medicare & Medicaid Services (CMS) guidance for states...
WASHINGTON—A newly released AARP poll shows that, in the run up to the Iowa Caucuses, health care is the top issue on the minds of women voters age 50 and up. The survey, conducted by The Harris...
WASHINGTON—AARP and AARP Foundation filed an amicus brief today urging the Supreme Court of the United States to review a case challenging the Patient Protection and Affordable Care Act (ACA)....
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to today’s Texas v. United States ruling on the...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to the U.S. Department of Health and Human Services...
WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on yesterday’s passage of FY 2020 appropriations bills H.R....
WASHINGTON—Today AARP released the findings of a nationwide poll that explores the priorities and concerns of a key group of voters that could help determine the 2020 presidential election and...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s vote by the U.S. House of Representatives on H.R....
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement urging the U.S. House of Representatives to vote in support of...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to the patent protections for biologic drugs and...